Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE
Descrição
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library
GSK's Nucala approved to treat chronic rhinosinusitis with nasal polyps - PharmaTimes
Mepolizumab reduces risk for repeat surgery for chronic rhinosinusitis with nasal polyps
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
FDA approves GSK's Nucala for use in adults with chronic rhinosinusitis with nasal polyps - PharmaLive
Study Designs NUCALA (mepolizumab) for HCPs
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up - Desrosiers - International Forum of Allergy & Rhinology - Wiley Online Library
KoreaMed Synapse
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study - Aikaterini Detoraki, Eugenio Tremante, Maria D'Amato, Cecilia Calabrese, Claudia
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect
Mepolizumab in chronic rhinosinusitis with nasal polyposis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
